Hemostemix Inc

Hemostemix Inc., based in Calgary, Alberta, is a pioneering company focused on transforming patients' lives through autologous stem cell therapeutics, specifically with their advanced treatment, ACP-01. Clinically proven to improve circulation, cardiac performance, and save limbs, the therapy also shows promise in enhancing cognitive function, particularly in patients with vascular dementia.

With a commitment to leading the field of regenerative medicine, Hemostemix has conducted seven clinical trials demonstrating the safety and efficacy of ACP-01. The company aims to address the needs of the 620 million individuals suffering from cardiovascular diseases and is actively expanding its treatment options to include heart, limb, and dementia-related conditions.

Generated from the website